Process View
A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to thyroid hormone"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.996 | ||
HNF4A | hepatocyte nuclear factor 4, alpha | 0.697 | ||
NPC2 | Niemann-Pick disease, type C2 | 0.635 | ||
PSAP | prosaposin | 0.578 | ||
LDB1 | LIM domain binding 1 | 0.393 | ||
ESRRG | estrogen-related receptor gamma | 0.321 | ||
PRDX1 | peroxiredoxin 1 | 0.305 | ||
CTSB | cathepsin B | 0.270 | ||
PPARG | peroxisome proliferator-activated receptor gamma | 0.268 | ||
FTL | ferritin, light polypeptide | 0.229 | ||
CD63 | CD63 molecule | 0.215 | ||
HEXB | hexosaminidase B (beta polypeptide) | 0.159 | ||
RGS2 | regulator of G-protein signaling 2, 24kDa | 0.150 | ||
CSTA | cystatin A (stefin A) | 0.138 | ||
MED10 | mediator complex subunit 10 | 0.102 | ||
INCENP | inner centromere protein antigens 135/155kDa | 0.094 | ||
COL1A1 | collagen, type I, alpha 1 | 0.085 | ||
IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.082 | ||
B2M | beta-2-microglobulin | 0.082 | ||
COL3A1 | collagen, type III, alpha 1 | 0.076 | ||
GATA2 | GATA binding protein 2 | 0.075 | Human | |
STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.071 | ||
TBX5 | T-box 5 | 0.061 | ||
KITLG | KIT ligand | 0.060 | ||
IFI30 | interferon, gamma-inducible protein 30 | 0.052 | ||
CTSL1 | cathepsin L1 | 0.052 | ||
TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.052 | ||
DYNLT1 | dynein, light chain, Tctex-type 1 | 0.052 | ||
NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.050 | ||
MED29 | mediator complex subunit 29 | 0.046 | ||
ANXA2 | annexin A2 | 0.043 | ||
LAMP1 | lysosomal-associated membrane protein 1 | 0.042 | ||
HLA-B | major histocompatibility complex, class I, B | 0.041 | ||
GPNMB | glycoprotein (transmembrane) nmb | 0.041 | ||
SEC24D | SEC24 family, member D (S. cerevisiae) | 0.039 | ||
FTH1 | ferritin, heavy polypeptide 1 | 0.038 | ||
TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.037 | ||
SAT1 | spermidine/spermine N1-acetyltransferase 1 | 0.037 | ||
TPP1 | tripeptidyl peptidase I | 0.035 | ||
S100A4 | S100 calcium binding protein A4 | 0.032 | ||
CDK19 | cyclin-dependent kinase 19 | 0.031 | ||
S100A10 | S100 calcium binding protein A10 | 0.031 | ||
AMBP | alpha-1-microglobulin/bikunin precursor | 0.031 | ||
MED14 | mediator complex subunit 14 | 0.030 | ||
RUNX1 | runt-related transcription factor 1 | 0.030 | ||
AURKB | aurora kinase B | 0.028 | ||
ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | 0.028 | ||
ZFPM1 | zinc finger protein, multitype 1 | 0.027 | ||
NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.025 | ||
NFE2L1 | nuclear factor (erythroid-derived 2)-like 1 | 0.024 | ||
LGMN | legumain | 0.023 | ||
GSTO1 | glutathione S-transferase omega 1 | 0.023 | ||
CTSD | cathepsin D | 0.023 | ||
CSTB | cystatin B (stefin B) | 0.023 | ||
LDB2 | LIM domain binding 2 | 0.022 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.021 | ||
IFNGR1 | interferon gamma receptor 1 | 0.020 | ||
IL10RB | interleukin 10 receptor, beta | 0.020 | ||
TGS1 | trimethylguanosine synthase 1 | 0.020 | ||
CDK8 | cyclin-dependent kinase 8 | 0.018 | ||
NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.018 | ||
ANXA5 | annexin A5 | 0.018 | ||
DAZAP2 | DAZ associated protein 2 | 0.018 | ||
CTSA | cathepsin A | 0.018 | ||
RXRA | retinoid X receptor, alpha | 0.018 | ||
MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.018 | ||
LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.018 | ||
MAPRE2 | microtubule-associated protein, RP/EB family, member 2 | 0.017 | ||
GRN | granulin | 0.017 | ||
SDCBP | syndecan binding protein (syntenin) | 0.016 | ||
MED13 | mediator complex subunit 13 | 0.016 | ||
TCF21 | transcription factor 21 | 0.016 | ||
LOX | lysyl oxidase | 0.016 | ||
GNS | glucosamine (N-acetyl)-6-sulfatase | 0.015 | ||
LY96 | lymphocyte antigen 96 | 0.014 | ||
HLA-C | major histocompatibility complex, class I, C | 0.014 | ||
SOD2 | superoxide dismutase 2, mitochondrial | 0.014 | ||
CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.014 | ||
SQRDL | sulfide quinone reductase-like (yeast) | 0.013 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.012 | ||
CTSH | cathepsin H | 0.012 | ||
DPP3 | dipeptidyl-peptidase 3 | 0.012 | ||
HLA-A | major histocompatibility complex, class I, A | 0.012 | ||
LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.011 | ||
CREG1 | cellular repressor of E1A-stimulated genes 1 | 0.011 | ||
S100A6 | S100 calcium binding protein A6 | 0.011 | ||
TGFBI | transforming growth factor, beta-induced, 68kDa | 0.011 | ||
THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.011 | ||
ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.011 | ||
TSC22D3 | TSC22 domain family, member 3 | 0.011 | ||
GATA4 | GATA binding protein 4 | 0.011 | Human | |
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.011 | ||
KYNU | kynureninase | 0.011 | ||
KLF13 | Kruppel-like factor 13 | 0.011 | Human | |
HMOX1 | heme oxygenase (decycling) 1 | 0.011 | ||
PRDX4 | peroxiredoxin 4 | 0.011 | ||
GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.011 | ||
KIF20A | kinesin family member 20A | 0.010 | ||
TMSB4X | thymosin beta 4, X-linked | 0.010 | ||
MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0.010 | ||
GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.010 |